# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-06T19:10:06.166540
**Route:** OpenRouter + LaTeX
**Paper Hash:** 537c6e7359f28274
**Tokens:** 20971 in / 1464 out
**Response SHA256:** e4ef052fe8a6f227

---

I checked the paper only for fatal errors in data-design alignment, regression sanity, completeness, and internal consistency.

I do **not** find any fatal errors.

Key checks completed:
- **Treatment timing vs. data coverage:** all treated cohorts used for the identified sample adopt between June 2021 and July 2022, within the stated DVF window of **2020H2–2024**. The paper correctly excludes **Paris (2019)** and **Lille (2020)** from the causally identified sample because they lack pre-treatment data.
- **Post-treatment observations:** each identified treatment cohort has post-treatment observations, and the appendix table on pre/post counts is internally consistent.
- **Treatment definition consistency:** treatment dates and treated commune counts are consistent across the text, treatment appendix, and sample definitions.
- **Regression sanity:** all reported coefficients, standard errors, \(R^2\), and sample sizes are numerically plausible. I found no impossible values, explosive SEs, negative SEs, \(R^2>1\), \(R^2<0\), NA/NaN/Inf, or obviously broken regression outputs.
- **Completeness:** regression tables report **N**, standard errors are present, and the main analyses described in the methods are shown in the results.
- **Internal consistency:** the main numerical claims in the abstract and results section match the reported tables; treated-sample counts also reconcile across tables.

ADVISOR VERDICT: PASS